ANN ARBOR, Mich. & PHILADELPHIA--(BUSINESS WIRE)--SensiGen LLC, a biotechnology company focused on developing proprietary gene-based molecular diagnostics announced today that it has been selected as one of only 12 life sciences companies to be featured presenters at the upcoming Mid-Atlantic Capital (MAC) Conference at the Philadelphia Marriott Downtown on October 23 and 24, 2007. The MAC Conference, a production of the Mid-Atlantic Capital Alliance, is the premier capital investor gathering in the Mid-Atlantic region, offering unparalleled speakers, panels, presentations, networking, and visibility opportunities to its sponsors and participating entrepreneurs.
